[1] |
World Health Organization.Global Cancer Statistics 2020[R].
|
[2] |
Allemani C, Matsuda T, Di Carlo V, et al.Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J].Lancet, 2018,391(10125): 1023-1075.DOI: 10.1016/S0140-6736(17)33326-3.
|
[3] |
樊嘉, 孙燕.NCCN肿瘤学临床实践指南(NCCN指南): 消化系统肿瘤指南(译)[M].北京:人民卫生出版社, 2017.
|
[4] |
中国临床肿瘤学会指南工作委员会组织.中国临床肿瘤学会(CSCO)原发性肝癌诊疗指南-2020[M].北京: 人民卫生出版社,2020.
|
[5] |
Inoue Y, Arita J, Sakamoto T, et al.Anatomical liver resections guided by 3-dimensional parenchymal staining using fusion indocyanine green fluorescence imaging[J].Ann Surg, 2015, 262(1): 105-111.DOI:10.1097/SLA.0000000000000775.
|
[6] |
Xu J, Fan J, Qin X, et al.Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)[J].J Cancer Res Clin Oncol, 2019, 145(3): 725-736.DOI: 10.1007/s00432-018-2795-1.
|
[7] |
Kodera Y, Fujitani K, Fukushima N, et al.Surgical resection of hepatic metastasis from gastric cancer: a review and new recommendation in the Japanese gastric cancer treatment guidelines[J].Gastric Cancer,2014, 17(2): 206-212.DOI: 10.1007/s10120-013-0299-x.
|
[8] |
Cummings MC, Simpson PT, Reid LE, et al.Metastatic progression of breast cancer: insights from 50 years of autopsies[J].J Pathol, 2014,232(1): 23-31.DOI: 10.1002/path.4288.
|
[9] |
Pagani O, Senkus E, Wood W, et al.International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?[J].J Natl Cancer Inst, 2010, 102(7): 456-463.DOI: 10.1093/jnci/djq029.
|
[10] |
Linhares E, Monteiro M, Kesley R, et al.Major hepatectomy for isolated metastases from gastric adenocarcinoma[J].HPB, 2003, 5(4):235-237.DOI: 10.1080/13651820310015815.
|
[11] |
de Ridder JM, Lemmens VP, Overbeek LH, et al.Liver resection for metastatic disease; A population-based analysis of trends[J].Dig Surg,2016, 33(2): 104-113.DOI: 10.1159/000441802.
|
[12] |
Dimick JB, Wainess RM, Cowan JA, et al.National trends in the use and outcomes of hepatic resection[J].J Am Coll Surg, 2004, 199(1):31-38.DOI: 10.1016/j.jamcollsurg.2004.03.005.
|
[13] |
Van Cutsem E, Nordlinger B, Cervantes A, et al.Advanced colorectal cancer: ESMO clinical practice guidelines for treatment[J].Ann Oncol, 2010, 21(Suppl 5): v93-v97.DOI: 10.1093/annonc/mdq222.
|
[14] |
中国医师协会外科医师分会,中华医学会外科学分会胃肠外科学组,中华医学会外科学分会结直肠外科学组,等.中国结直肠癌肝转移诊断和综合治疗指南(2023版)[J].中华消化外科杂志,2023,22(1):1-28.DOI:10.3760/cma.j.cn11 5610-20221228-00762.
|
[15] |
Cooper AB, Curley SA.Surgical treatment of colorectal liver metastases[J].Chin Clin Oncol, 2013, 2(2): 15.DOI: 10.3978/j.issn.2304-3865.2013.03.02.
|
[16] |
Hao CY, Ji JF.Surgical treatment of liver metastases of colorectal cancer: Strategies and controversies in 2006f.Eur J Surg Oncol, 2006,32(5): 473-483.DOI: 10.1016/j.ejso.2006.02.016.
|
[17] |
Adam R, Delvart V, Pascal G, et al.Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival[J].Ann Surg, 2004, 240(4):644-657;discussion 657-658.DOI: 10.1097/01.sla.0000141198.92114.f6.
|
[18] |
Kato T, Yasui K, Hirai T, et al.Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions[J].Dis Colon Rectum, 2003, 46(10 Suppl): S22-S31.DOI: 10.1097/01.DCR.0000089106.71914.00.
|
[19] |
冯翠菊.现代武器智慧的眼睛——精确制导技术[J].现代物理知识,2008, 20(1): 41-44.
|
[20] |
陈耀龙, 杨克虎, 王小钦, 等.中国制订/修订临床诊疗指南的指导原则(2022版)[J].中华医学杂志, 2022, 102(10): 697-703.DOI:10.3760/cma.j.cn112137-20211228-02911.
|
[21] |
Zeng MS, Ye HY, Guo L, et al.Gd-EOB-DTPA-enhanced magnetic resonance imaging for focal liver lesions in Chinese patients: a multicenter, open-label, phase Ⅲ study[J].Hepatobiliary Pancreat Dis Int,2013,12(6):607-616.DOI: 10.1016/s1499-3872(13)60096-x.
|
[22] |
Jhaveri KS, Fischer SE, Hosseini-Nik H, et al.Prospective comparison of gadoxetic acid-enhanced liver MRI and contrast-enhanced CT with histopathological correlation for preoperative detection of colorectal liver metastases following chemotherapy and potential impact on surgical plan[J].HPB, 2017, 19(11): 992-1000.DOI: 10.1016/j.hpb.2017.06.014.
|
[23] |
Yoo SH, Choi JY, Jang JW, et al.Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma[J].Ann Surg Oncol,2013, 20(9):2893-2900.DOI:10.1245/s10434-013-3001-y.
|
[24] |
Motosugi U, Ichikawa T, Sou H, et al.Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging[J].Radiology,2010, 256(1): 151-158.DOI: 10.1148/radiol.10091885.
|
[25] |
Omata M, Cheng AL, Kokudo N, et al.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update[J].Hepatol Int, 2017, 11(4): 317-370.DOI: 10.1007/s12072-017-9799-9.
|
[26] |
Watanabe R, Matsumura M, Munemasa T, et al.Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver[J].Invest Radiol,2007, 42(9): 643-651.DOI: 10.1097/RLI.0b013e31805f2682.
|
[27] |
Claudon M, Dietrich CF, Choi BI, et al.Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS[J].Ultraschall Med, 2013, 34(1): 11-29.DOI: 10.1055/s-0032-1325499.
|
[28] |
Watanabe R, Matsumura M, Chen CJ, et al.Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent; detection of hepatic tumors in a rabbit model[J].Biol Pharm Bull, 2003, 26(9): 1272-1277.DOI: 10.1248/bpb.26.1272.
|
[29] |
Yang Y, Liu C, Yan J, et al.Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis[J].Abdom Radiol, 2021, 46(10): 4619-4628.DOI: 10.1007/s00261-021-03141-5.
|
[30] |
Hatanaka K, Kudo M, Minami Y, et al.Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT[J].Oncology, 2008, 75(Suppl 1): 42-47.DOI: 10.1159/000173423.
|
[31] |
吴旋音, 田果, 曹红翠, 等.Sonazoid超声造影与增强磁共振成像对肝脏局灶性病变的诊断价值比较[J].中华超声影像学杂志, 2021,30(6): 494-499.DOI: 10.3760/cma.j.cn131148-20201223-00963.
|
[32] |
Hsiao CY, Chen PD, Huang KW.A prospective assessment of the diagnostic value of contrast-enhanced ultrasound, dynamic computed tomography and magnetic resonance imaging for patients with small liver tumors[J].J Clin Med, 2019, 8(9): 1353.DOI: 10.3390/jcm8091353.
|
[33] |
Kudo M, Hatanaka K, Maekawa K.Newly developed novel ultrasound technique, defect reperfusion ultrasound imaging, using sonazoid in the management of hepatocellular carcinoma[J].Oncology, 2010,78(Suppl 1): 40-45.DOI: 10.1159/000315229.
|
[34] |
Kudo M.Defect reperfusion imaging with sonazoid®: a breakthrough in hepatocellular carcinoma[J].Liver Cancer, 2016, 5(1): 1-7.DOI:10.1159/000367760.
|
[35] |
Xu J, Liu Y, Wu M, et al.Role of Sonazoid enhanced ultrasound assistant laparoscopic radiofrequency ablation in treating liver malignancy-a single-center retrospective cohort study[J].Cancer Med,2023, 12(8): 9075-9084.DOI: 10.1002/cam4.5613.
|
[36] |
Lv K, Zhai H, Jiang Y, et al.Prospective assessment of diagnostic efficacy and safety of SonazoidTM and SonoVue® ultrasound contrast agents in patients with focal liver lesions[J].Abdom Radiol, 2021,46(10): 4647-4659.DOI: 10.1007/s00261-021-03010-1.
|
[37] |
Moriyasu F, Itoh K.Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions:phase 3 multicenter clinical trial[J].AJR Am J Roentgenol, 2009,193(1): 86-95.DOI: 10.2214/AJR.08.1618.
|
[38] |
Shagdarsuren B, Tamai H, Shingaki N, et al.Contribution of contrastenhanced sonography with perfluorobutane microbubbles for diagnosis of recurrent hepatocellular carcinoma[J].J Ultrasound Med, 2016,35(7): 1383-1391.DOI: 10.7863/ultra.15.08042.
|
[39] |
Nanashima A, Tobinaga S, Abo T, et al.Usefulness of sonazoidultrasonography during hepatectomy in patients with liver tumors:a preliminary study[J].J Surg Oncol, 2011, 103(2): 152-157.DOI:10.1002/jso.21782.
|
[40] |
Kawada N, Ohkawa K, Tanaka S, et al.Improved diagnosis of welldifferentiated hepatocellular carcinoma with gadolinium ethoxybenzyl diethylene triamine pentaacetic acid-enhanced magnetic resonance imaging and Sonazoid contrast-enhanced ultrasonography[J].Hepatol Res, 2010, 40(9): 930-936.DOI: 10.1111/j.1872-034X.2010.00697.x.
|
[41] |
Kudo M, Hatanaka K, Kumada T, et al.Double-contrast ultrasound:a novel surveillance tool for hepatocellular carcinoma[J].Am J Gastroenterol, 2011, 106(2): 368-370.DOI: 10.1038/ajg.2010.432.
|
[42] |
Kudo M, Ueshima K, Osaki Y, et al.B-mode ultrasonography versus contrast-enhanced ultrasonography for surveillance of hepatocellular carcinoma: a prospective multicenter randomized controlled trial[J].Liver Cancer, 2019, 8(4): 271-280.DOI: 10.1159/000501082.
|
[43] |
Kobayashi K, Maruyama H, Kiyono S, et al.Histology-based assessment of sonazoid-enhanced ultrasonography for the diagnosis of liver metastasis[J].Ultrasound Med Biol, 2017, 43(10): 2151-2158.DOI: 10.1016/j.ultrasmedbio.2017.06.014.
|
[44] |
Mishima M, Toh U, Iwakuma N, et al.Evaluation of contrast Sonazoid-enhanced ultrasonography for the detection of hepatic metastases in breast cancer[J].Breast Cancer, 2016, 23(2): 231-241.DOI: 10.1007/s12282-014-0560-0.
|
[45] |
Imai K, Adam R, Baba H.How to increase the resectability of initially unresectable colorectal liver metastases: a surgical perspective[J].Ann Gastroenterol Surg, 2019, 3(5): 476-486.DOI: 10.1002/ags3.12276.
|
[46] |
Barimani D, Kauppila JH, Sturesson C, et al.Imaging in disappearing colorectal liver metastases and their accuracy: a systematic review[J].World J Surg Oncol, 2020, 18(1): 264.DOI: 10.1186/s12957-020-02037-w.
|
[47] |
Kopetz S, Chang GJ, Overman MJ, et al.Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy[J].J Clin Oncol, 2009, 27(22):3677-3683.DOI: 10.1200/JCO.2008.20.5278.
|
[48] |
Folprecht G, Grothey A, Alberts S, et al.Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates[J].Ann Oncol, 2005, 16(8): 1311-1319.DOI: 10.1093/annonc/mdi246.
|
[49] |
Oba A, Mise Y, Ito H, et al.Clinical implications of disappearing colorectal liver metastases have changed in the era of hepatocytespecific MRI and contrast-enhanced intraoperative ultrasonography[J].HPB, 2018, 20(8): 708-714.DOI: 10.1016/j.hpb.2018.02.377.
|
[50] |
Luo W, Numata K, Morimoto M, et al.Three-dimensional contrastenhanced sonography of vascular patterns of focal liver tumors:pilot study of visualization methods[J].AJR Am J Roentgenol, 2009,192(1): 165-173.DOI: 10.2214/AJR.08.1107.
|
[51] |
王铭, 唐红.吲哚菁绿清除试验的临床应用[J].临床肝胆病杂志,2017, 33(6): 1183-1187.DOI: 10.3969/j.issn.101-5256.2017.06.036.
|
[52] |
Kubota K, Makuuchi M, Kusaka K, et al.Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors[J].Hepatology, 1997, 26(5):1176-1181.DOI: 10.1053/jhep.1997.v26.pm0009362359.
|
[53] |
Imamura H, Seyama Y, Kokudo N, et al.One thousand fifty-six hepatectomies without mortality in 8 years[J].Arch Surg, 2003,138(11): 1198-1206;discussion1206.DOI: 10.1001/archsurg.138.11.1198.
|
[54] |
中华人民共和国国家卫生健康委员会医政医管局.原发性肝癌诊疗规范(2019年版)[J].中华肝脏病杂志,2020,28(2):112-128.DOI:10.3760/cma.j.issn.1007-3418.2020.02.004.
|
[55] |
元云飞, 李国辉, 李锦清, 等.术前肝储备功能评估对原发性肝癌手术的价值[J].中华肿瘤杂志, 1995, 17(5): 377-380.
|
[56] |
Kamiyama T, Kakisaka T, Orimo T.Current role of intraoperative ultrasonography in hepatectomy[J].Surg Today, 2021, 51(12): 1887-1896.DOI: 10.1007/s00595-020-02219-9.
|
[57] |
Joo I.The role of intraoperative ultrasonography in the diagnosis and management of focal hepatic lesions[J].Ultrasonography, 2015,34(4): 246-257.DOI: 10.14366/usg.15014.
|
[58] |
Uchiyama K, Ueno M, Ozawa S, et al.Combined use of contrastenhanced intraoperative ultrasonography and a fluorescence navigation system for identifying hepatic metastases[J].World J Surg, 2010, 34(12): 2953-2959.DOI: 10.1007/s00268-010-0764-1.
|
[59] |
Takahashi M, Hasegawa K, Arita J, et al.Contrast-enhanced intraoperative ultrasonography using perfluorobutane microbubbles for the enumeration of colorectal liver metastases[J].Br J Surg, 2012,99(9): 1271-1277.DOI: 10.1002/bjs.8844.
|
[60] |
Mitsunori Y, Tanaka S, Nakamura N, et al.Contrast-enhanced intraoperative ultrasound for hepatocellular carcinoma: high sensitivity of diagnosis and therapeutic impact[J].J Hepatobiliary Pancreat Sci, 2013, 20(2): 234-242.DOI: 10.1007/s00534-012-0507-9.
|
[61] |
Arita J, Takahashi M, Hata S, et al.Usefulness of contrastenhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma[J].Ann Surg, 2011, 254(6): 992-999.DOI:10.1097/SLA.0b013e31822518be.
|
[62] |
Arita J, Ono Y, Takahashi M, et al.Routine preoperative liverspecific magnetic resonance imaging does not exclude the necessity of contrast-enhanced intraoperative ultrasound in hepatic resection for colorectal liver metastasis[J].Ann Surg, 2015, 262(6): 1086-1091.DOI: 10.1097/SLA.0000000000001085.
|
[63] |
段文斌, 薛蓉, 王子承, 等.术中Sonazoid超声造影在特殊部位肝细胞癌经腹腔镜微波消融中的应用价值[J].中国普通外科杂志,2022, 31(7): 880-889.DOI:10.7659/j.issn.1005-6947.2022.07.004.
|
[64] |
王子承, 段文斌, 魏荣光, 等.术中超声及术中超声造影在巨大肝恶性肿瘤手术治疗中的应用(附视频)[J].中国普通外科杂志,2022, 31(7): 920-929.DOI: 10.7659/j.issn.1005-6947.2022.07.009.
|
[65] |
Barr RG, Huang P, Luo Y, et al.Contrast-enhanced ultrasound imaging of the liver: a review of the clinical evidence for SonoVue and Sonazoid[J].Abdom Radiol, 2020, 45(11): 3779-3788.DOI:10.1007/s00261-020-02573-9.
|
[66] |
Li C, Liu Y, Xu J, et al.Contrast-enhanced intraoperative ultrasonography with kupffer phase may change treatment strategy of metastatic liver tumors - A single-centre prospective study[J].Ther Clin Risk Manag, 2021, 17: 789-796.DOI: 10.2147/TCRM.S317469.
|
[67] |
Abo T, Nanashima A, Tobinaga S, et al.Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging[J].Eur J Surg Oncol, 2015, 41(2): 257-264.DOI: 10.1016/j.ejso.2014.09.008.
|
[68] |
Huang Z, Zhu RH, Xin JY, et al.HCC treated with immune checkpoint inhibitors: a hyper-enhanced rim on Sonazoid-CEUS Kupffer phase images is a predictor of tumor response[J].Eur Radiol,2023, 33(6): 4389-4400.DOI: 10.1007/s00330-022-09339-5.
|
[69] |
左慧, 陈雯, 杨豪, 等.Sonazoid超声造影评估转移性肝癌化疗疗效的应用价值[J].临床超声医学杂志, 2022, 24(11): 816-821.DOI:10.16245/j.cnki.issn1008-6978.2022.11.014.
|
[70] |
Arita J, Ono Y, Takahashi M, et al.Usefulness of contrast-enhanced intraoperative ultrasound in identifying disappearing liver metastases from colorectal carcinoma after chemotherapy[J].Ann Surg Oncol,2014, 21(Suppl 3): S390-S397.DOI: 10.1245/s10434-014-3576-y.
|
[71] |
Tani K, Shindoh J, Akamatsu N, et al.Management of disappearing lesions after chemotherapy for colorectal liver metastases: Relation between detectability and residual tumors[J].J Surg Oncol, 2018,117(2): 191-197.DOI: 10.1002/jso.24805.
|
[72] |
Stavrou GA, Stang A, Raptis DA, et al.Intraoperative (contrastenhanced) ultrasound has the highest diagnostic accuracy of any imaging modality in resection of colorectal liver metastases[J].J Gastrointest Surg, 2021, 25(12): 3160-3169.DOI: 10.1007/s11605-021-04925-2.
|
[73] |
Numata K, Morimoto M, Ogura T, et al.Ablation therapy guided by contrast-enhanced sonography with Sonazoid for hepatocellular carcinoma lesions not detected by conventional sonography[J].J Ultrasound Med, 2008, 27(3): 395-406.DOI: 10.7863/jum.2008.27.3.395.
|
[74] |
Ishizawa T, Fukushima N, Shibahara J, et al.Real-time identification of liver cancers by using indocyanine green fluorescent imaging[J].Cancer, 2009, 115(11): 2491-2504.DOI: 10.1002/cncr.24291.
|
[75] |
Mondal SB, Gao S, Zhu N, et al.Real-time fluorescence imageguided oncologic surgery[M]//Emerging Applications of Molecular Imaging to Oncology.Amsterdam: Elsevier, 2014: 171-211.DOI: 10.1016/b978-0-12-411638-2.00005-7.
|
[76] |
Kudo H, Ishizawa T, Tani K, et al.Visualization of subcapsular hepatic malignancy by indocyanine-green fluorescence imaging during laparoscopic hepatectomy[J].Surg Endosc, 2014, 28(8):2504-2508.DOI: 10.1007/s00464-014-3468-z.
|
[77] |
Jones AD, Wilton JC.Can intra-operative fluorescence play a significant role in hepatobiliary surgery?[J].Eur J Surg Oncol, 2017,43(9): 1622-1627.DOI: 10.1016/j.ejso.2017.02.015.
|
[78] |
Hu Z, Fang C, Li B, et al.First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows[J].Nat Biomed Eng, 2020,4(3):259-271.DOI:10.1038/s41551-019-0494-0.
|
[79] |
董家鸿, 黄志强.精准肝切除——21世纪肝脏外科新理念[J].中华外科杂志, 2009, 47(21): 1601-1605.DOI: 10.3760/cma.j.issn.0529-5815.2009.21.001.
|
[80] |
Makuuchi M, Hasegawa H, Yamazaki S.Ultrasonically guided subsegmentectomy[J].Surg Gynecol Obstet, 1985, 161(4): 346-350.
|
[81] |
中国研究型医院学会肝胆胰外科专业委员会, 《中华消化外科杂志》编辑委员会, 董家鸿, 等.腹腔镜解剖性肝切除手术操作流程及技术标准中国专家共识(2023版)[J].中华消化外科杂志, 2023,22(7): 810-823.DOI: 10.3760/cma.j.cn115610-20230714-00410.
|
[82] |
Eguchi S, Kanematsu T, Arii S, et al.Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey[J].Surgery, 2008, 143(4): 469-475.DOI: 10.1016/j.surg.2007.12.003.
|
[83] |
Yamashita YI, Taketomi A, Itoh S, et al.Longterm favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience[J].J Am Coll Surg, 2007, 205(1):19-26.DOI: 10.1016/j.jamcollsurg.2007.01.069.
|
[84] |
Kim YK, Han HS, Yoon YS, et al.Total anatomical laparoscopic liver resection of segment 4 (S4), extended S4, and subsegments S4a and S4b for hepatocellular carcinoma[J].J Laparoendosc Adv Surg Tech A, 2015, 25(5): 375-379.DOI: 10.1089/lap.2014.0443.
|
[85] |
张雅敏, 王建.解剖性肝切除与非解剖性肝切除对肝癌预后影响的研究进展[J].中华外科杂志, 2016, 54(12): 947-950.DOI:10.3760/cma.j.issn.0529-5815.2016.12.016.
|
[86] |
Shindoh J, Hasegawa K, Inoue Y, et al.Risk factors of post-operative recurrence and adequate surgical approach to improve long-term outcomes of hepatocellular carcinoma[J].HPB, 2013, 15(1): 31-39.DOI: 10.1111/j.1477-2574.2012.00552.x.
|
[87] |
Ishizawa T, Saiura A, Kokudo N.Clinical application of indocyanine green-fluorescence imaging during hepatectomy[J].Hepatobiliary Surg Nutr, 2016, 5(4): 322-328.DOI: 10.21037/hbsn.2015.10.01.
|
[88] |
Miyata A, Ishizawa T, Tani K, et al.Reappraisal of a dye-staining technique for anatomic hepatectomy by the concomitant use of indocyanine green fluorescence imaging[J].J Am Coll Surg, 2015,221(2): e27-e36.DOI: 10.1016/j.jamcollsurg.2015.05.005.
|
[89] |
Chiow AKH, Rho SY, Wee IJY, et al.Robotic ICG guided anatomical liver resection in a multi-centre cohort: an evolution from “positive staining” into “negative staining” method[J].HPB, 2021, 23(3):475-482.DOI: 10.1016/j.hpb.2020.08.005.
|
[90] |
Ishizawa T, Zuker NB, Kokudo N, et al.Positive and negative staining of hepatic segments by use of fluorescent imaging techniques during laparoscopic hepatectomy[J].Arch Surg, 2012, 147(4): 393-394.DOI: 10.1001/archsurg.2012.59.
|
[91] |
Ueno M, Hayami S, Sonomura T, et al.Indocyanine green fluorescence imaging techniques and interventional radiology during laparoscopic anatomical liver resection (with video)[J].Surg Endosc,2018, 32(2): 1051-1055.DOI: 10.1007/s00464-017-5997-8.
|
[92] |
Mizuno T, Sheth R, Yamamoto M, et al.Laparoscopic glissonean pedicle transection (takasaki) for negative fluorescent counterstaining of segment 6[J].Ann Surg Oncol, 2017, 24(4): 1046-1047.DOI:10.1245/s10434-016-5721-2.
|
[93] |
Felli E, Ishizawa T, Cherkaoui Z, et al.Laparoscopic anatomical liver resection for malignancies using positive or negative staining technique with intraoperative indocyanine green-fluorescence imaging[J].HPB, 2021, 23(11): 1647-1655.DOI: 10.1016/j.hpb.2021.05.006.
|
[94] |
Makuuchi M, Imamura H, Sugawara Y, et al.Progress in surgical treatment of hepatocellular carcinoma[J].Oncology, 2002, 62(Suppl 1): 74-81.DOI: 10.1159/000048280.
|
[95] |
王宏光.吲哚菁绿肝段染色在腹腔镜肝癌切除中应用及意义[J].中国实用外科杂志, 2018, 38(4): 376-378.DOI: 10.19538/j.cjps.issn1005-2208.2018.04.09.
|
[96] |
Aoki T, Koizumi T, Mansour DA, et al.Ultrasound-guided preoperative positive percutaneous indocyanine green fluorescence staining for laparoscopic anatomical liver resection[J].J Am Coll Surg, 2020, 230(3): e7-e12.DOI: 10.1016/j.jamcollsurg.2019.11.004.
|
[97] |
Terasawa M, Ishizawa T, Mise Y, et al.Applications of fusionfluorescence imaging using indocyanine green in laparoscopic hepatectomy[J].Surg Endosc, 2017, 31(12): 5111-5118.DOI:10.1007/s00464-017-5576-z.
|
[98] |
Urade T, Sawa H, Iwatani Y, et al.Laparoscopic anatomical liver resection using indocyanine green fluorescence imaging[J].Asian J Surg, 2020, 43(1): 362-368.DOI: 10.1016/j.asjsur.2019.04.008.
|
[99] |
Nomi T, Hokuto D, Yoshikawa T, et al.A novel navigation for laparoscopic anatomic liver resection using indocyanine green fluorescence[J].Ann Surg Oncol, 2018, 25(13): 3982.DOI: 10.1245/s10434-018-6768-z.
|
[100] |
Xu Y, Chen M, Meng X, et al.Laparoscopic anatomical liver resection guided by real-time indocyanine green fluorescence imaging: experience and lessons learned from the initial series in a single center[J].Surg Endosc, 2020, 34(10): 4683-4691.DOI:10.1007/s00464-020-07691-5.
|
[101] |
Wakabayashi T, Cacciaguerra AB, Abe Y, et al.Indocyanine green fluorescence navigation in liver surgery: a systematic review on dose and timing of administration[J].Ann Surg, 2022, 275(6): 1025-1034.DOI: 10.1097/SLA.0000000000005406.
|
[102] |
Wang X, Teh CSC, Ishizawa T, et al.Consensus guidelines for the use of fluorescence imaging in hepatobiliary surgery[J].Ann Surg,2021, 274(1): 97-106.DOI: 10.1097/SLA.0000000000004718.
|
[103] |
Lubner MG, Mankowski Gettle L, Kim DH, et al.Diagnostic and procedural intraoperative ultrasound: technique, tips and tricks for optimizing results[J].Br J Radiol, 2021, 94(1121): 20201406.DOI:10.1259/bjr.20201406.
|
[104] |
Peyrat P, Blanc E, Guillermet S, et al.HEPATOFLUO: a prospective monocentric study assessing the benefits of indocyanine green (ICG)fluorescence for hepatic surgery[J].J Surg Oncol, 2018, 117(5): 922-927.DOI: 10.1002/jso.25011.
|
[105] |
Liu B, Liu T, Su M, et al.Improving the surgical effect for primary liver cancer with intraoperative fluorescence navigation compared with intraoperative ultrasound[J].Med Sci Monit, 2019, 25: 3406-3416.DOI: 10.12659/MSM.916423.
|
[106] |
Aoki T, Murakami M, Koizumi T, et al.Determination of the surgical margin in laparoscopic liver resections using infrared indocyanine green fluorescence[J].Langenbecks Arch Surg, 2018, 403(5): 671-680.DOI: 10.1007/s00423-018-1685-y.
|
[107] |
Maruyama H, Takahashi M, Ishibashi H, et al.Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography[J].Liver Int, 2009, 29(5): 708-714.DOI: 10.1111/j.1478-3231.2008.01875.x.
|
[108] |
Ng KKC, Chok KH, Chan AY, et al.Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma[J].Br J Surg, 2017, 104(13): 1775-1784.DOI: 10.1002/bjs.10677.
|
[109] |
Kim GA, Shim JH, Kim MJ, et al.Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas[J].Br J Surg, 2016, 103(1): 126-135.DOI: 10.1002/bjs.9960.
|
[110] |
Lee HW, Lee JM, Yoon JH, et al.A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma[J].Ann Surg Treat Res, 2018, 94(2): 74-82.DOI: 10.4174/astr.2018.94.2.74.
|
[111] |
Dohmen T, Kataoka E, Yamada I, et al.Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma[J].Intern Med, 2012, 51(1): 1-7.DOI: 10.2169/internalmedicine.51.6042.
|
[112] |
Masuzaki R, Shiina S, Tateishi R, et al.Utility of contrast-enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma[J].J Gastroenterol Hepatol, 2011, 26(4):759-764.DOI: 10.1111/j.1440-1746.2010.06559.x.
|
[113] |
Nishigaki Y, Hayashi H, Tomita E, et al.Usefulness of contrastenhanced ultrasonography using Sonazoid for the assessment of therapeutic response to percutaneous radiofrequency ablation for hepatocellular carcinoma[J].Hepatol Res, 2015, 45(4): 432-440.DOI: 10.1111/hepr.12370.
|
[114] |
Jeon HJ, Eun HS, Kwon IS, et al.Outcomes of laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for hepatocellular carcinoma[J].Surg Endosc, 2023, 37(7): 5176-5189.DOI: 10.1007/s00464-023-09956-1.
|
[115] |
Eun HS, Lee BS, Kwon IS, et al.Advantages of laparoscopic radiofrequency ablation over percutaneous radiofrequency ablation in hepatocellular carcinoma[J].Dig Dis Sci, 2017, 62(9): 2586-2600.DOI: 10.1007/s10620-017-4688-6.
|
[116] |
Kwak MH, Lee MW, Ko SE, et al.Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma[J].Ultrasonography, 2022, 41(3): 543-552.DOI: 10.14366/usg.21241.
|